Endothelial progenitor cells: Functions and clinical application in cardiac and vascular diseases

Ya Li Huang, Yan Wang, Tong D Lu

Research output: Contribution to journalArticle

Abstract

Circulating endothelial progenitor cells (EPCs) derived from bone marrow are capable of endocrine, reendothelialization of injured blood vessels and neovascularization of ischemic lesions; besides, they also play a major role in the pathogenesis of atherosclerosis. However, the number and functions of circulating EPCs are greatly declined in patients suffering from cardiovascular diseases. Functions of EPCs are associated with not only pathophysiological factors such as aging, hypertension, diabetes and hyperlipidemia, but also personal lifestyle such as exercise, body weight and smoking, which directly influence the development of cardiovascular diseases. In this review, we mainly focus on the relationship between EPCs and cardiovascular risk factors and the potential roles of EPC therapy for cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)545-548
Number of pages4
JournalAcademic Journal of Second Military Medical University
Volume31
Issue number5
DOIs
StatePublished - May 20 2010

Fingerprint

Vascular Diseases
Heart Diseases
Cardiovascular Diseases
Cell- and Tissue-Based Therapy
Hyperlipidemias
Blood Vessels
Life Style
Atherosclerosis
Bone Marrow
Smoking
Body Weight
Endothelial Progenitor Cells
Exercise
Hypertension

Keywords

  • Cardiovascular diseases
  • Endothelial progenitor cells
  • Risk factors
  • Therapeutic uses

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Endothelial progenitor cells : Functions and clinical application in cardiac and vascular diseases. / Huang, Ya Li; Wang, Yan; Lu, Tong D.

In: Academic Journal of Second Military Medical University, Vol. 31, No. 5, 20.05.2010, p. 545-548.

Research output: Contribution to journalArticle

@article{2d52694225294d52bc4344bf436a4d6d,
title = "Endothelial progenitor cells: Functions and clinical application in cardiac and vascular diseases",
abstract = "Circulating endothelial progenitor cells (EPCs) derived from bone marrow are capable of endocrine, reendothelialization of injured blood vessels and neovascularization of ischemic lesions; besides, they also play a major role in the pathogenesis of atherosclerosis. However, the number and functions of circulating EPCs are greatly declined in patients suffering from cardiovascular diseases. Functions of EPCs are associated with not only pathophysiological factors such as aging, hypertension, diabetes and hyperlipidemia, but also personal lifestyle such as exercise, body weight and smoking, which directly influence the development of cardiovascular diseases. In this review, we mainly focus on the relationship between EPCs and cardiovascular risk factors and the potential roles of EPC therapy for cardiovascular diseases.",
keywords = "Cardiovascular diseases, Endothelial progenitor cells, Risk factors, Therapeutic uses",
author = "Huang, {Ya Li} and Yan Wang and Lu, {Tong D}",
year = "2010",
month = "5",
day = "20",
doi = "10.3724/SP.J.1008.2010.00545",
language = "English (US)",
volume = "31",
pages = "545--548",
journal = "Academic Journal of Second Military Medical University",
issn = "0258-879X",
publisher = "Second Military Medical University Press",
number = "5",

}

TY - JOUR

T1 - Endothelial progenitor cells

T2 - Functions and clinical application in cardiac and vascular diseases

AU - Huang, Ya Li

AU - Wang, Yan

AU - Lu, Tong D

PY - 2010/5/20

Y1 - 2010/5/20

N2 - Circulating endothelial progenitor cells (EPCs) derived from bone marrow are capable of endocrine, reendothelialization of injured blood vessels and neovascularization of ischemic lesions; besides, they also play a major role in the pathogenesis of atherosclerosis. However, the number and functions of circulating EPCs are greatly declined in patients suffering from cardiovascular diseases. Functions of EPCs are associated with not only pathophysiological factors such as aging, hypertension, diabetes and hyperlipidemia, but also personal lifestyle such as exercise, body weight and smoking, which directly influence the development of cardiovascular diseases. In this review, we mainly focus on the relationship between EPCs and cardiovascular risk factors and the potential roles of EPC therapy for cardiovascular diseases.

AB - Circulating endothelial progenitor cells (EPCs) derived from bone marrow are capable of endocrine, reendothelialization of injured blood vessels and neovascularization of ischemic lesions; besides, they also play a major role in the pathogenesis of atherosclerosis. However, the number and functions of circulating EPCs are greatly declined in patients suffering from cardiovascular diseases. Functions of EPCs are associated with not only pathophysiological factors such as aging, hypertension, diabetes and hyperlipidemia, but also personal lifestyle such as exercise, body weight and smoking, which directly influence the development of cardiovascular diseases. In this review, we mainly focus on the relationship between EPCs and cardiovascular risk factors and the potential roles of EPC therapy for cardiovascular diseases.

KW - Cardiovascular diseases

KW - Endothelial progenitor cells

KW - Risk factors

KW - Therapeutic uses

UR - http://www.scopus.com/inward/record.url?scp=77953278561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953278561&partnerID=8YFLogxK

U2 - 10.3724/SP.J.1008.2010.00545

DO - 10.3724/SP.J.1008.2010.00545

M3 - Article

AN - SCOPUS:77953278561

VL - 31

SP - 545

EP - 548

JO - Academic Journal of Second Military Medical University

JF - Academic Journal of Second Military Medical University

SN - 0258-879X

IS - 5

ER -